Antipsychotics Flashcards
chlorpromazine
Phenothiazines, neuroleptic
- TYPICAL ANTIPSYCHOTIC/ CONVENTIONAL ANTIPSYCHOTIC
Chemical type 1
- Aliphatic side chain
Primarily used to treat schizophrenia
- block response to increased/abnormal neurotransmitter levels
- Does not cure/elimiate fundamental and chronic though disorder
- Decrease the intensity of hallucinations and delusions
Selective for DA receptor
- Low Potency = not selective for D2 (desired) or D1
Metabolism:
- CYP2D6 and CYP3A4
- Significant delay of onset 4-8 weeks
Side Effect:
- Blockade of Cholinergic Muscarinic Receptor
- Hyperthermia, tachycardia, urinary retention, memory impairment, blurred vision, constipation, and confusion
- Blockade of alpha Adrenergic Receptor
- Vasodilation, orthostatic hypotension, light headedness, reflex tachycardia and sexual dysfunction
- Pituitary D2 Receptor Block
- Increased prolactin release
- Infertility and impotence
H1 histamine receptor Block
- Sedation and Weight Gain
fluphenazine
Phenothiazine
Chemical Type I:
- Piperazine side chain
Primarily used to treat schizophrenia
- block response to increased/abnormal neurotransmitter levels
- Does not cure/elimiate fundamental and chronic though disorder
- Decrease the intensity of hallucinations and delusions
Selective for DA receptor
- High Potency= more selective for D2 (desired) or D1
Metabolism:
- CYP2D6 and CYP3A4
- Significant delay of onset 4-8 weeks
Fluphenazine Decanoate is a slow release formula (2-4 weeks)
- Deep gluteal intramuscular injection
- Used for patients non-compliant with oral meds
Mechanism:
- Inhibits ATP to cAMP formation
Side Effect:
- Blockade of Cholinergic Muscarinic Receptor
- Hyperthermia, tachycardia, urinary retention, memory impairment, blurred vision, constipation, and confusion
- Blocks Dopamine D2R
- Pituitary D2 Receptor Block
- Increased prolactin release
- Infertility and impotence
H1 histamine receptor Block
- Sedation and Weight Gain
Side Effect: - Neuroleptic Malignant Syndrome (NMS) - Instability and collapse of ANS - Excessive sweating/salivary excretion - Unstable BP and CV instabitility - Fever, muscle stiffness, delirium, stupr - Incidence: 0.2 to 3.2% of patients Fatal in 10% of these - Less likely if had been stable before - Manifested in patients with Parkinson's disease who stop/reduce dose of Dopaminergics
thiothixene
Thioxanthene
Antipsychotic Chemical Type 1
Typical Antipsychotic (conventional antipsychotic)
Medium Efficacy: moderate more selectivity for D2 receptors
Metabolism:
- CYP2D6 and CYP3A4
- Significant delay of onset 4-8 weeks
Mechanism:
- Inhibits ATP to cAMP formation
Side Effect:
- Blockade of Cholinergic Muscarinic Receptor
- Hyperthermia, tachycardia, urinary retention, memory impairment, blurred vision, constipation, and confusion
- Blocks Dopamine D2R
- Pituitary D2 Receptor Block
- Increased prolactin release
- Infertility and impotence
H1 histamine receptor Block
- Sedation and Weight Gain
Side Effect: - Neuroleptic Malignant Syndrome (NMS) - Instability and collapse of ANS - Excessive sweating/salivary excretion - Unstable BP and CV instabitility - Fever, muscle stiffness, delirium, stupr - Incidence: 0.2 to 3.2% of patients Fatal in 10% of these - Less likely if had been stable before - Manifested in patients with Parkinson's disease who stop/reduce dose of Dopaminergics
haloperidol
Antipsychotic
Chemical Type 1
Butyrophenones
Typical Antipsychotic (conventional antipsychotic)
High Efficacy: More selectivity for D2 receptors
Metabolism:
- CYP2D6 and CYP3A4
- Significant delay of onset 4-8 weeks
Haloperidol Decanoate is a slow release formula (2-4 weeks)
- Deep gluteal intramuscular injection
- Used for patients non-compliant with oral meds
Mechanism:
- Inhibits ATP to cAMP formation
Side Effect:
- Blockade of Cholinergic Muscarinic Receptor
- Hyperthermia, tachycardia, urinary retention, memory impairment, blurred vision, constipation, and confusion
- Blocks Dopamine D2R
- MOST PROMINENT Pituitary D2 Receptor Block
- prolactin release
- Infertility and impotence
H1 histamine receptor Block
- Sedation and Weight Gain
Side Effect: - Neuroleptic Malignant Syndrome (NMS) - Instability and collapse of ANS - Excessive sweating/salivary excretion - Unstable BP and CV instabitility - Fever, muscle stiffness, delirium, stupr - Incidence: 0.2 to 3.2% of patients Fatal in 10% of these - Less likely if had been stable before - Manifested in patients with Parkinson's disease who stop/reduce dose of Dopaminergics
aripiprazole
Antipsychotic Chemical Type II
2nd generation antipsychotic
Dopamine Partial Agonist
3rd generation
Competitive partial agonist for dopamine receptors (selectivity for D2 receptors) antagonizes serotonin receptors
Discontinuation must be done gradually to avoid marked withdrawal or relapse
Side Effects:
- Blocks other receptors
- Alpha Adrenergic
- Vasodilation, orthostatic hypotension, light headedness, reflex tachycardia, sexual dysfunction
- Dopamine receptor
- Serotonin receptor
- Sedation and weight gain
clozapine
Atypical Antipsychotic
Chemical type II
Synthetic BZ derivative
Selective antagonist for serotonin and dopamine receptors
Drug induced agranulocytosis, leukopenia
Blocks Activation of postsynaptic 5-HT2A receptor
Blocks activation of postsynaptic D2 Receptors
Blocks
- Cholinergic Receptor
- alpha-adrenergic
- Dopamine receptor
- Serotonin receptor
- H histamine receptor
Metabolism: Induction of CYP1A2
Inhibits CYP2D6 and CYP3A4 to decrease drug elimination
Acute adverse events only with overdose
- Hypotension, hyper/hypothermia, seizures and coma, Ventricular tachycardia
olanzapine
Atypical Antipsychotic
Chemical type II
Synthetic BZ derivative
Selective antagonist for serotonin and dopamine receptors
Blocks Activation of postsynaptic 5-HT2A receptor
Blocks activation of postsynaptic D2 Receptors
Blocks
- Cholinergic Receptor
- alpha-adrenergic
- Dopamine receptor
- Serotonin receptor
- H histamine receptor
Metabolism: Induction of CYP1A2
Inhibits CYP2D6 and CYP3A4 to decrease drug elimination
Acute adverse events only with overdose
- Hypotension, hyper/hypothermia, seizures and coma, Ventricular tachycardia
Outperformed Other Typical Antipsychotics
- NIMH sponsored CATIE study
- Superior Efficacy
Severe metabolic side effects
- Major weight gain
- Increase in glucose, cholesterol, and TGs
paliperidone
Antipsychotic Chemical Type II
2nd generation antipsychotic
Selective antagonist for serotonin and dopamine receptors
Metabolized by p450
A Major Active Metabolite of Risperidone
- CYP2D6 for elimination
Side Effects:
- Blocks other receptors
- Dopamine receptor
- Serotonin receptor
- Sedation and weight gain
Inhibition of Cyp2D6 and CYP3A4 decreases drug elimination lesser extent
quetiapine
Atypical Antipsychotic
Chemical type II
Synthetic BZ derivative
Selective antagonist for serotonin and dopamine receptors
Blocks Activation of postsynaptic 5-HT2A receptor
Blocks activation of postsynaptic D2 Receptors
Blocks
- Cholinergic Receptor
- alpha-adrenergic
- Dopamine receptor
- Serotonin receptor
- H histamine receptor
Metabolism: Induction of CYP1A2
Inhibits CYP2D6 and CYP3A4 to decrease drug elimination
Acute adverse events only with overdose
- Hypotension, hyper/hypothermia, seizures and coma, Ventricular tachycardia
Outperformed Other Typical Antipsychotics
- NIMH sponsored CATIE study
- Superior Efficacy
Severe metabolic side effects
- Major weight gain
- Increase in glucose, cholesterol, and TGs
risperidone
2nd generation antipsychotic
Selective antagonist for serotonin and dopamine receptors
Metabolized by p450
Produces Major Active Metabolite Paliperidone
- CYP2D6 for elimination
Risperiodone microspheres
- Slow release formula (2-4 weeks
- Deep gluteal intramuscular injection
- Used for patients non compliant with oral med
Side Effects:
- Blocks other receptors
- Dopamine receptor
- Serotonin receptor
- Sedation and weight gain
Inhibition of Cyp2D6 and CYP3A4 decreases drug elimination lesser extent
prochlorperazine
Atypical antipsychotic
D2 receptor blockade goes to antipsychotic effects
H1 histamine receptor blockade– antiemetic effects
promethazine
Atypical antipsychotic
D2 receptor blockade goes to antipsychotic effects
H1 histamine receptor blockade– antiemetic effects